Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection

Cancer

Volumn 98, Issue 2, 2003, Pages 315-319

  Nucci, Marcio ^a   Anaissie, Elias J ^b   Queiroz Telles, Flavio ^c   Martins, Carlos A ^d   Trabasso, Plinio ^e   Solza, Cristiana ^f   Mangini, Claudia ^g   Simões, Belinda P ^h   Colombo, Arnaldo L ⁱ   Vaz, Jorge ^j   Levy, Carlos E ^k   Costa, Silvia ^h   Moreira, Vaneusa A ^c   Oliveira, José Salvador ⁱ   Paraguay, Nestor ^k   Duboc, Gisele ^h   Voltarelli, Julio C ^h   Maiolino, Angelo ^a   Pasquini, Ricardo ^c   Souza, Cármino A ^e  

^a University Hospital   (Brazil)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^e UNIVERSITY OF CAMPINAS   (Brazil)

^f STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^g Hospital Do Câncer   (Brazil)

^h UNIVERSITY OF SÃO PAULO   (Brazil)

ⁱ FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^j Hospital Santa Lucia   (Brazil)

^k CENTRO INFANTIL BOLDRINI   (Brazil)

more..

Author keywords

Cancer; Fusariosis; Fusarium; Mortality; Prognostic factor

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CORTICOSTEROID; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; KETOCONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FUSARIUM; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; MYCOSIS; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FUSARIUM; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MYCOSES; PROGNOSIS; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS;

EID: 0038345403     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11510     Document Type: Article

References (25)

1. de Pauw BE, Meunier F. The challenge of invasive fungal infection. Chemotherapy. 1999;45(Suppl 1):1-14.
2. Abi-Said D, Anaissie E, Uzun O, et al. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis. 1997;24:1122-1128.
3. McNeil MM, Nash SL, Hajjeh RA, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis. 2001;33:641-647.
4. van Burik JH, Leisenring W, Myerson D, et al. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients. Medicine (Baltimore). 1998;77:246-254.
5. Baddley JW, Stroud TP, Salzman D, Pappas PG. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin Infect Dis. 2001;32:1319-1324.
6. Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore). 2000;79:250-260.
7. Merz WG, Karp JE, Hoagland M, et al. Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis. 1988;158:1046-1055.
8. Nucci M, Spector N, Lucena S, et al. Three cases of infection with Fusarium species in neutropenic patients. Eur J Clin Microbiol Infect Dis. 1992;11:1160-1162.
9. Spielberger RT, Falleroni MJ, Coene AJ, Larson RA. Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient. Clin Infect Dis. 1993;16:528-530.
10. Hennequin C, Benkerrou M, Gaillard JL, Blanche S, Fraitag S. Role of granulocyte colony-stimulating factor in the management of infection with Fusarium oxysporum in a neutropenic child. Clin Infect Dis. 1994;18:490-491.
11. Velasco E, Martins CA, Nucci M. Successful treatment of catheter-related fusarial infection in immunocompromised children. Eur J Clin Microbiol Infect Dis. 1995;14:697-699.
12. Hennequin C, Lavarde V, Poirot JL, et al. Invasive Fusarium infections: a retrospective survey of 31 cases. The French 'Groupe d'Etudes des Mycoses Opportunistes' GEMO. J Med Vet Mycol. 1997;35:107-114.
13. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood. 1997;90:999-1008.
14. Girmenia C, Iori AP, Boecklin F, et al. Fusarium infections in patients with severe aplastic anemia: review and implications for management. Haematologica. 1999;84:114-118.
15. Guarro J, Nucci M, Akiti T, Gene J. Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient. J Clin Microbiol. 2000;38:3460-3462.
16. Nucci M, Queiroz-Telles F, Trabasso P, et al. Epidemiologic study of systemic Fusarium infection in Brazil [abstract]. Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, September 17-20, 2000. Washington, DC: Amreican Society for Microbiology, 2000.
17. Ascioglú S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7-14.
18. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001;32:358-366.
19. Nucci M, Silveira MI, Spector N, et al. Risk factors for death among cancer patients with fungemia. Clin Infect Dis. 1998;27:107-111.
20. Ribaud P, Chastang C, Latge JP, et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis. 1999;28:322-330.
21. Uzun O, Anaissie EI. Predictors of outcome in cancer patients with candidemia. Ann Oncol. 2000;11:1517-1521.
22. Anaissie EJ, Kuchar RT, Rex JH, et al. Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis. 2001;33:1871-1878.
23. Dignani MC, Anaissie EJ, Hester JP, et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia. 1997;11:1621-1630.
24. Hachem RY, Raad II, Afif CM, et al. An open, non-comparative multicenter study to evaluate efficacy and safety of posaconazole (SCH 56592) in the treatment of invasive fungal infections refractory to or intolerant to standard therapy [abstract]. Programs and abstracts of the 40th Interscience Symposium on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, September 17-20, 2000 Washington, DC: American Society for Microbiology, 2000.
25. Reyes GH, Long L, Hossain M, Ghannoum MA. Evaluation of voriconazole efficacy in the treatment of murine fusariosis [abstract]. In: Programs and abstracts of the 41th Interscience Symposium on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, December 16-19, 2001. Washington, DC: American Society for Microbiology, 2001.